A

Allied Corp
OTC:ALID

Watchlist Manager
Allied Corp
OTC:ALID
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: 57.8k USD

Relative Value

ALID doesn't have a meaningful market cap.

The Relative Value of one ALID stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.0005 USD, Allied Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALID Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
5
Median 3Y
97
Median 5Y
111.1
Industry
2.7
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.6
Industry
21.5
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-8.1
Industry
16.7
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-8.9
Industry
23
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.3
Industry
2.3
vs History
52
vs Industry
3
Median 3Y
128.3
Median 5Y
146.8
Industry
2.9
vs History
vs Industry
1
Median 3Y
-23.5
Median 5Y
-33.7
Industry
5.6
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-4.5
Industry
13.2
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-4.4
Industry
16.6
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-10.9
Industry
15.8
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-9.2
Industry
19
vs History
6
vs Industry
7
Median 3Y
7
Median 5Y
9
Industry
2

Multiples Across Competitors

ALID Competitors Multiples
Allied Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Allied Corp
OTC:ALID
57.7k USD 0.6 -0 -2.5 -2.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.2 37 39.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
213.8B GBP 5 30.7 108.7 159.1
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
261.8B USD 4.1 13.8 9.8 11.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.6 13.9 9.7 11.3
IE
Endo International PLC
LSE:0Y5F
212.8B USD 91.8 -72.8 337 845
US
Pfizer Inc
NYSE:PFE
141.6B USD 2.3 14.4 7.4 10.1
P/E Multiple
Earnings Growth PEG
CA
A
Allied Corp
OTC:ALID
Average P/E: 24.2
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.2
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.7
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.9
3%
4.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -72.8 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.4
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
A
Allied Corp
OTC:ALID
Average EV/EBITDA: 439.6
Negative Multiple: -2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
1%
9.7
IE
E
Endo International PLC
LSE:0Y5F
337
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
A
Allied Corp
OTC:ALID
Average EV/EBIT: 1 882.9
Negative Multiple: -2.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.6
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
845
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
7%
1.4